0001458729-16-000002.txt : 20161121 0001458729-16-000002.hdr.sgml : 20161121 20161121105854 ACCESSION NUMBER: 0001458729-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161121 DATE AS OF CHANGE: 20161121 EFFECTIVENESS DATE: 20161121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MBF Therapeutics, Inc. CENTRAL INDEX KEY: 0001458729 IRS NUMBER: 262735190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-274857 FILM NUMBER: 162009434 BUSINESS ADDRESS: STREET 1: 640 WOODBROOK DRIVE CITY: AMBLER STATE: PA ZIP: 19002 BUSINESS PHONE: (215)620-3699 MAIL ADDRESS: STREET 1: 640 WOODBROOK DRIVE CITY: AMBLER STATE: PA ZIP: 19002 D 1 primary_doc.xml X0707 D LIVE 0001458729 MBF Therapeutics, Inc. 640 WOODBROOK DRIVE AMBLER PA PENNSYLVANIA 19002 (215)620-3699 DELAWARE None None Corporation true Thomas Tillett c/o MBF Therapeutics, Inc. 640 Woodbrook Drive Ambler PA PENNSYLVANIA 19002 Executive Officer Director Christopher M. Cashman c/o MBF Therapeutics, Inc. 640 Woodbrook Drive Ambler PA PENNSYLVANIA 19002 Director Biotechnology Decline to Disclose 06b false 2016-11-10 false true true true false 0 1095185 1095185 0 Includes cash proceeds and proceeds of indebtedness of the Issuer converted in the offering into preferred shares and common warrants of the Company. false 14 0 0 0 false MBF Therapeutics, Inc. Thomas Tillett Thomas Tillett President 2016-11-21